Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericarditis | 1 | 2004 | 3 | 0.240 |
Why?
|
Mesothelioma | 1 | 2004 | 21 | 0.240 |
Why?
|
Heart Neoplasms | 1 | 2004 | 33 | 0.240 |
Why?
|
Polyps | 1 | 2004 | 12 | 0.230 |
Why?
|
Vocal Cords | 1 | 2004 | 18 | 0.230 |
Why?
|
Laryngeal Diseases | 1 | 2004 | 22 | 0.230 |
Why?
|
Thyroiditis, Autoimmune | 4 | 2005 | 15 | 0.230 |
Why?
|
Pericardium | 1 | 2004 | 97 | 0.230 |
Why?
|
Down Syndrome | 1 | 2004 | 120 | 0.220 |
Why?
|
HLA-DR3 Antigen | 3 | 2004 | 7 | 0.160 |
Why?
|
Thyroglobulin | 4 | 2005 | 17 | 0.140 |
Why?
|
HLA-DQ Antigens | 2 | 2002 | 19 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2004 | 1140 | 0.090 |
Why?
|
Saphenous Vein | 1 | 2005 | 61 | 0.060 |
Why?
|
Vasodilation | 1 | 2005 | 85 | 0.060 |
Why?
|
Aneurysm | 1 | 2005 | 53 | 0.060 |
Why?
|
Aneurysm, False | 1 | 2005 | 60 | 0.060 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2005 | 114 | 0.060 |
Why?
|
Microvilli | 1 | 2004 | 22 | 0.060 |
Why?
|
Keratins | 1 | 2004 | 48 | 0.060 |
Why?
|
Cardiac Tamponade | 1 | 2004 | 11 | 0.060 |
Why?
|
Vimentin | 1 | 2004 | 47 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 218 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2004 | 164 | 0.060 |
Why?
|
Ventricular Fibrillation | 1 | 2004 | 85 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 226 | 0.060 |
Why?
|
Dyspnea | 1 | 2004 | 87 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2004 | 61 | 0.060 |
Why?
|
Genes, MHC Class II | 1 | 2002 | 29 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 307 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2004 | 483 | 0.050 |
Why?
|
Biomarkers, Tumor | 1 | 2004 | 508 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2004 | 1033 | 0.030 |
Why?
|
Male | 4 | 2005 | 37321 | 0.030 |
Why?
|
HLA-DR Antigens | 2 | 2004 | 41 | 0.030 |
Why?
|
Mice, Inbred NOD | 2 | 2004 | 138 | 0.030 |
Why?
|
Humans | 6 | 2005 | 68618 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2004 | 7277 | 0.020 |
Why?
|
Mice | 4 | 2005 | 8474 | 0.020 |
Why?
|
Female | 3 | 2005 | 38074 | 0.020 |
Why?
|
Adult | 1 | 2004 | 21403 | 0.020 |
Why?
|
Animals | 4 | 2005 | 20881 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2005 | 42 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2005 | 107 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2005 | 98 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2005 | 75 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2005 | 99 | 0.020 |
Why?
|
Receptor, ErbB-2 | 1 | 2005 | 129 | 0.020 |
Why?
|
HLA-DR Serological Subtypes | 1 | 2004 | 2 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2004 | 32 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2004 | 38 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 532 | 0.010 |
Why?
|
Histocytochemistry | 1 | 2004 | 149 | 0.010 |
Why?
|
Coronary Disease | 1 | 2005 | 358 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 511 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 631 | 0.010 |
Why?
|
HLA-DRB1 Chains | 1 | 2002 | 21 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 1083 | 0.010 |
Why?
|
Immunization | 1 | 2002 | 86 | 0.010 |
Why?
|
Autoantigens | 1 | 2002 | 91 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 1447 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2002 | 156 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2002 | 179 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 301 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2005 | 1851 | 0.010 |
Why?
|
Gene Expression | 1 | 2002 | 770 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 1196 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 2791 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2005 | 1615 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2002 | 2550 | 0.010 |
Why?
|
Aged | 1 | 2005 | 14862 | 0.010 |
Why?
|